Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aldeyra Will Receive A Option Fee Of $1M And Upfront Payment Of $100M Less Option Fees If AbbVie Chooses To Exercise; Would Be Eligible To Receive Up To $300M In Regulatory And Commercial Milestone Payments, Inclusive Of A $100M Paymeent Upon FDA Approval

Author: Benzinga Newsdesk | November 01, 2023 10:54am

Posted In: ABBV ALDX